MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Impairment of intangible assets
Stock-based compensation
Depreciation expense
Negative Cash Flow Breakdown
Trade and other payables
Prepaid expenses
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-15,790
-1,178
-2,314
-939
Depreciation expense
2
2
3
0
Loss on disposal
-
0
-
-
Stock-based compensation
105
182
108
206
Impairment of intangible assets
13,533
-
-
-
Change in fair value of derivative warrant liabilities
0
0
40
-1,427
Deferred income tax benefit
-
-1,700
0
0
Receivables
0
0
0
0
Prepaid expenses
174
-136
103
-84
Trade and other payables
-897
863
36
-1,067
Net cash used in operating activities
-3,221
-1,695
-2,230
-3,143
Maturity of short-term investments
-
0
0
-
Purchase of short-term investments
-
0
0
0
Net cash provided by investing activities
-
0
0
0
Proceeds from issuance of common stock from common warrant exercise
-
0
4,040
-
Gross proceeds from issuance of common stock and warrants from private placement
-
0
-
-
Payment of stock issuance costs
0
0
0
0
Net cash used in financing activities
0
0
4,040
0
Net decrease in cash and cash equivalents
-3,221
-1,695
1,810
-3,143
Cash and cash equivalents, beginning of period
16,977
16,862
16,862
22,133
Cash and cash equivalents, end of period
13,756
16,977
18,672
16,862
Cash
2,712
-
-
-
Cash equivalents
11,044
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and cash...
-$3,221K
(-51.36%↓ Y/Y)
Impairment of intangible
assets
$13,533K
Stock-based compensation
$105K
(-65.23%↓ Y/Y)
Depreciation expense
$2K
(0.00%↑ Y/Y)
Net cash used in
operating activities
-$3,221K
(-78.85%↓ Y/Y)
Canceled cashflow
$13,640K
Net loss
-$15,790K
(-369.66%↓ Y/Y)
Trade and other
payables
-$897K
(-226.16%↓ Y/Y)
Prepaid expenses
$174K
(270.21%↑ Y/Y)
Buy us a coffee
Grace Therapeutics, Inc. (GRCE)
Grace Therapeutics, Inc. (GRCE)